These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist. Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, U-97018. Kushida H; Nomura S; Morita O; Harasawa Y; Suzuki M; Nakano M; Ozawa K; Kunihara M J Pharmacol Exp Ther; 1995 Sep; 274(3):1042-53. PubMed ID: 7562467 [TBL] [Abstract][Full Text] [Related]
5. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism. Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114 [TBL] [Abstract][Full Text] [Related]
6. Blockade of the renin-angiotensin system in heart failure in conscious dogs. Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902 [TBL] [Abstract][Full Text] [Related]
7. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist. Olins GM; Corpus VM; Chen ST; McMahon EG; Palomo MA; McGraw DE; Smits GJ; Null CL; Brown MA; Bittner SE J Cardiovasc Pharmacol; 1993 Oct; 22(4):617-25. PubMed ID: 7505365 [TBL] [Abstract][Full Text] [Related]
9. Vascular angiotensin II receptor and calcium signaling in toadfish. Qin ZL; Yan HQ; Nishimura H Gen Comp Endocrinol; 1999 Jul; 115(1):122-31. PubMed ID: 10375471 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog. Lee BH; Lee SH; Jung YS; Seo HW; Yoo SE; Shin HS J Pharm Pharmacol; 1999 Oct; 51(10):1191-200. PubMed ID: 10579691 [TBL] [Abstract][Full Text] [Related]
11. EXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist. Wong PC; Duncia JV; Chiu AT; Olson RE; Rominger DH; Tam SW; Timmermans PB J Pharmacol Exp Ther; 1993 Nov; 267(2):641-7. PubMed ID: 7902431 [TBL] [Abstract][Full Text] [Related]
12. Discovery of losartan, the first angiotensin II receptor antagonist. Timmermans PB; Duncia JV; Carini DJ; Chiu AT; Wong PC; Wexler RR; Smith RD J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479 [TBL] [Abstract][Full Text] [Related]
13. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249 [TBL] [Abstract][Full Text] [Related]
15. Sympatho-inhibitory properties of various AT1 receptor antagonists. Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061 [TBL] [Abstract][Full Text] [Related]